Dry eye disease affects nearly 7% of adults in the United States. Despite this, patients may not know many causes, symptoms, risk factors, and preventative measures for the disease. What should you be telling your patients about dry eye disease?
Researchers evaluated the relationship between orbital fat strain ratios and glaucoma, CCT relationship.
The FDA has approved Soliris (eculizumab; Alexion Pharmaceuticals, Inc) for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult patients who are anti-aquaporin-4 (AQP4) antibody positive.
Results from the small study are promising.
In women with NMOSD, 42.9% of pregnancies ended in miscarriage compared with 12-24% in the general population.
Those treated with levodopa saw macular degeneration onset later than controls.
Optic ultrasound is a fast and easy, noninvasive way to measure intracranial pressure.
An anti-LINGO-1 monoclonal antibody showed some success in treating optic neuritis but missed many study endpoints.
Mycophenolate mofetil effectively eliminated relapses in 60% of patients with neuromyelitis optica spectrum disorder.
Multiple sclerosis patients with uveitis tend to be female and older in age, according to new research.